The board of directors of Libertine Holdings PLC, known for its development of Linear Generator technology, has announced the commencement of a formal review to explore strategic options aimed at maximizing value for its shareholders, employees, and other stakeholders. This Strategic Review comes at a crucial time as the company seeks additional resources to advance […]
Biocon Limited (BSE code: 532523, NSE: BIOCON), a leader in global biopharmaceutical innovations, has announced a pivotal licensing and supply agreement with Brazil’s Biomm S.A., a specialty pharmaceutical company, to commercialize Semaglutide, a drug aimed at enhancing glycemic control in adults with type-2 diabetes. This exclusive partnership allows Biocon to handle the development, manufacturing, and […]
